PeriGen Acquires WatchChild and Receives Investment from Ambina Partners
PRINCETON, NJ and GREENWICH, CT - September 27, 2016
PeriGen®, the leading developer of fetal surveillance systems using artificial intelligence (AI) for clinical and operational benefit, today announced that Perigen has acquired the WatchChild® Fetal Monitoring System from Hill-Rom Holdings, Inc. (NYSE:HRC). The combination creates the most comprehensive perinatal safety platform available, and marks a new era in obstetric solutions.
In conjunction with the WatchChild acquisition, PeriGen has closed an investment round led by Ambina Partners that includes participation by existing PeriGen investors Galen Partners and Trident Capital. As a result of this investment, Greg Share, Ambina Partners' founder, will join PeriGen's board, together with John Gomez, CEO of cyber security firm Sensato and former CTO of Allscripts.
Commented Greg Share, Chairman of Ambina Partners, "I am very pleased to lead the investment in PeriGen as they acquire WatchChild. I am particularly looking forward to supporting Matthew Sappern and his exceptional management team as they drive the business forward."
PeriGen offers innovative perinatal software solutions that incorporate artificial intelligence (AI) features to enhance clinical efficiency and standardization of care during childbirth. Led by skilled OB practitioners and IT visionaries, PeriGen has created the PeriCALM platform to provides consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriCALM clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation.